Siemens Healthineers AG (0PMJ.L)
EUR 44.72
(-0.42%)
EUR 44.72
(-0.42%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 1.94 Billion EUR | 28.69% |
| 2023 | 1.5 Billion EUR | -25.96% |
| 2022 | 2.03 Billion EUR | 18.01% |
| 2021 | 1.72 Billion EUR | 22.4% |
| 2020 | 1.41 Billion EUR | -9.96% |
| 2019 | 1.56 Billion EUR | 23.87% |
| 2018 | 1.26 Billion EUR | -11.35% |
| 2017 | 1.42 Billion EUR | 8.85% |
| 2016 | 1.31 Billion EUR | 2.66% |
| 2015 | 1.27 Billion EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 426 Million EUR | -1.16% |
| 2024 Q1 | 431 Million EUR | -19.74% |
| 2024 Q3 | 469 Million EUR | 10.09% |
| 2023 FY | 1.5 Billion EUR | -25.96% |
| 2023 Q3 | 445 Million EUR | 323.81% |
| 2023 Q4 | 537 Million EUR | 20.67% |
| 2023 Q1 | 421 Million EUR | -33.28% |
| 2023 Q2 | 105 Million EUR | -75.06% |
| 2022 Q1 | 466 Million EUR | 0.87% |
| 2022 Q4 | 631 Million EUR | 73.83% |
| 2022 Q3 | 363 Million EUR | -37.31% |
| 2022 Q2 | 579 Million EUR | 24.25% |
| 2022 FY | 2.03 Billion EUR | 18.01% |
| 2021 Q1 | 432 Million EUR | 0.7% |
| 2021 FY | 1.72 Billion EUR | 22.4% |
| 2021 Q4 | 462 Million EUR | 18.46% |
| 2021 Q3 | 390 Million EUR | -11.96% |
| 2021 Q2 | 443 Million EUR | 2.55% |
| 2020 Q1 | 301 Million EUR | -40.04% |
| 2020 FY | 1.41 Billion EUR | -9.96% |
| 2020 Q2 | 411 Million EUR | 36.54% |
| 2020 Q4 | 429 Million EUR | 58.89% |
| 2020 Q3 | 270 Million EUR | -34.31% |
| 2019 Q4 | 502 Million EUR | 44.25% |
| 2019 Q3 | 348 Million EUR | -7.45% |
| 2019 Q2 | 376 Million EUR | 10.26% |
| 2019 Q1 | 341 Million EUR | -7.84% |
| 2019 FY | 1.56 Billion EUR | 23.87% |
| 2018 Q4 | 370 Million EUR | 29.82% |
| 2018 FY | 1.26 Billion EUR | -11.35% |
| 2018 Q3 | 285 Million EUR | -6.25% |
| 2018 Q2 | 304 Million EUR | -0.98% |
| 2018 Q1 | 307 Million EUR | -31.47% |
| 2017 Q1 | 359 Million EUR | 0.0% |
| 2017 FY | 1.42 Billion EUR | 8.85% |
| 2017 Q3 | 320 Million EUR | 6.67% |
| 2017 Q2 | 300 Million EUR | -16.43% |
| 2017 Q4 | 448 Million EUR | 40.0% |
| 2016 FY | 1.31 Billion EUR | 2.66% |
| 2015 FY | 1.27 Billion EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cegedim SA | -7.4 Million EUR | 26318.442% |
| Guerbet SA | 23.86 Million EUR | -8037.099% |
| Nexus AG | 24.03 Million EUR | -7981.228% |
| Bastide Le Confort Médical SA | -900 Thousand EUR | 215877.778% |
| Revenio Group Oyj | 19.1 Million EUR | -10062.751% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | -1658.532% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | -846.394% |
| LNA Santé SA | 23.4 Million EUR | -8195.955% |
| Medios AG | 18.81 Million EUR | -10224.296% |
| Equasens Société anonyme | 47.04 Million EUR | -4027.787% |
| Stratec SE | 13.06 Million EUR | -14761.866% |